353 related articles for article (PubMed ID: 19435750)
21. Neuromyelitis optica in Brazil: a study on clinical and prognostic factors.
Bichuetti DB; Oliveira EM; Souza NA; Rivero RL; Gabbai AA
Mult Scler; 2009 May; 15(5):613-9. PubMed ID: 19299436
[TBL] [Abstract][Full Text] [Related]
22. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica.
Ito S; Mori M; Makino T; Hayakawa S; Kuwabara S
Ann Neurol; 2009 Sep; 66(3):425-8. PubMed ID: 19798642
[TBL] [Abstract][Full Text] [Related]
23. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
Misu T; Fujihara K; Itoyama Y
Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis.
Warabi Y; Yagi K; Hayashi H; Matsumoto Y
J Neurol Sci; 2006 Nov; 249(2):145-52. PubMed ID: 16860825
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of diagnostic value for NMO-IgG in patients with neuromyelitis optica].
Yang Y; Huang DH; Wu L; Wu WP
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):606-9. PubMed ID: 20450783
[TBL] [Abstract][Full Text] [Related]
26. Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica.
Zhang L; Wu A; Zhang B; Chen S; Men X; Lin Y; Lu Z
Mult Scler; 2014 Apr; 20(4):418-23. PubMed ID: 23886831
[TBL] [Abstract][Full Text] [Related]
27. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
[TBL] [Abstract][Full Text] [Related]
28. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis.
Brum DG; Barreira AA; dos Santos AC; Kaimen-Maciel DR; Matiello M; Costa RM; Deghaide NH; Costa LS; Louzada-Junior P; Diniz PR; Comini-Frota ER; Mendes-Junior CT; Donadi EA
Mult Scler; 2010 Jan; 16(1):21-9. PubMed ID: 19995845
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and treatment of neuromyelitis optica.
Wingerchuk DM
Neurologist; 2007 Jan; 13(1):2-11. PubMed ID: 17215722
[TBL] [Abstract][Full Text] [Related]
30. Neuromyelitis optica and non organ-specific autoimmunity.
Pittock SJ; Lennon VA; de Seze J; Vermersch P; Homburger HA; Wingerchuk DM; Lucchinetti CF; Zéphir H; Moder K; Weinshenker BG
Arch Neurol; 2008 Jan; 65(1):78-83. PubMed ID: 18195142
[TBL] [Abstract][Full Text] [Related]
31. Brain magnetic resonance imaging abnormalities in neuromyelitis optica.
Li Y; Xie P; Lv F; Mu J; Li Q; Yang Q; Hu M; Tang H; Yi J
Acta Neurol Scand; 2008 Oct; 118(4):218-25. PubMed ID: 18384459
[TBL] [Abstract][Full Text] [Related]
32. Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands.
Nakamura M; Nakashima I; Sato S; Miyazawa I; Fujihara K; Itoyama Y
Mult Scler; 2007 Apr; 13(3):332-5. PubMed ID: 17439901
[TBL] [Abstract][Full Text] [Related]
33. Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics.
Adoni T; Lino AM; da Gama PD; Apóstolos-Pereira SL; Marchiori PE; Kok F; Callegaro D
Mult Scler; 2010 Jan; 16(1):81-6. PubMed ID: 19995833
[TBL] [Abstract][Full Text] [Related]
34. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.
Yanagawa K; Kawachi I; Toyoshima Y; Yokoseki A; Arakawa M; Hasegawa A; Ito T; Kojima N; Koike R; Tanaka K; Kosaka T; Tan CF; Kakita A; Okamoto K; Tsujita M; Sakimura K; Takahashi H; Nishizawa M
Neurology; 2009 Nov; 73(20):1628-37. PubMed ID: 19917985
[TBL] [Abstract][Full Text] [Related]
35. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
Kinoshita M; Nakatsuji Y; Kimura T; Moriya M; Takata K; Okuno T; Kumanogoh A; Kajiyama K; Yoshikawa H; Sakoda S
Biochem Biophys Res Commun; 2009 Sep; 386(4):623-7. PubMed ID: 19545538
[TBL] [Abstract][Full Text] [Related]
36. NMO-IgG predicts the outcome of recurrent optic neuritis.
Matiello M; Lennon VA; Jacob A; Pittock SJ; Lucchinetti CF; Wingerchuk DM; Weinshenker BG
Neurology; 2008 Jun; 70(23):2197-200. PubMed ID: 18434643
[TBL] [Abstract][Full Text] [Related]
37. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
[TBL] [Abstract][Full Text] [Related]
38. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
Bradl M; Misu T; Takahashi T; Watanabe M; Mader S; Reindl M; Adzemovic M; Bauer J; Berger T; Fujihara K; Itoyama Y; Lassmann H
Ann Neurol; 2009 Nov; 66(5):630-43. PubMed ID: 19937948
[TBL] [Abstract][Full Text] [Related]
39. Neuromyelitis optica with linear enhancement of corpus callosum in brain magnetic resonance imaging with contrast: a case report.
Sahraian MA; Moghadasi AN; Owji M; Naghshineh H; Minagar A
J Med Case Rep; 2015 Jun; 9():137. PubMed ID: 26059535
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of neuromyelitis optica with a pediatric onset.
Collongues N; Marignier R; Zéphir H; Papeix C; Fontaine B; Blanc F; Rodriguez D; Fleury M; Vukusic S; Pelletier J; Audoin B; Thouvenot E; Camu W; Barroso B; Ruet A; Brochet B; Vermersch P; Confavreux C; de Seze J
Neurology; 2010 Sep; 75(12):1084-8. PubMed ID: 20855851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
